SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000898432-06-000551
Filing Date
2006-06-15
Accepted
2006-06-15 17:28:59
Documents
2
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BIOTECHNOLOGY VALUE FUND, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.INVESTMENT 10, L.L.C.

Document Format Files

Seq Description Document Type Size
1 IMMUNOGEN bvf-immunogen_sc13g.htm SC 13G 102354
2 EXHIBIT 1 exhibit_99.htm EX-99 12941
  Complete submission text file 0000898432-06-000551.txt   117517
Mailing Address 128 SIDNEY ST CAMBRIDGE MA 02139
Business Address 128 SIDNEY ST CAMBRIDGE MA 02139 6179952506
IMMUNOGEN INC (Subject) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 0606
Type: SC 13G | Act: 34 | File No.: 005-40774 | Film No.: 06908175
SIC: 2834 Pharmaceutical Preparations

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice